Literature DB >> 12490658

The obesity epidemic: pathophysiology and consequences of obesity.

F Xavier Pi-Sunyer1.   

Abstract

Obesity has reached epidemic proportions in the United States: more than 20% of adults are clinically obese as defined by a body mass index of 30 kg/m(2) or higher, and an additional 30% are overweight. Environmental, behavioral, and genetic factors have been shown to contribute to the development of obesity. Elevated body mass index, particularly caused by abdominal or upper-body obesity, has been associated with a number of diseases and metabolic abnormalities, many of which have high morbidity and mortality. These include hyperinsulinemia, insulin resistance, type 2 diabetes, hypertension, dyslipidemia, coronary heart disease, gallbladder disease, and certain malignancies. This underscores the importance of identifying people at risk for obesity and its related disease states.

Entities:  

Mesh:

Year:  2002        PMID: 12490658     DOI: 10.1038/oby.2002.202

Source DB:  PubMed          Journal:  Obes Res        ISSN: 1071-7323


  196 in total

1.  An examination of sociodemographic, health, psychological factors, and fruit and vegetable consumption among overweight and obese U.S. veterans.

Authors:  Linda K Ko; Marlyn Allicok; Marci K Campbell; Carmina G Valle; Janelle Armstrong-Brown; Carol Carr; Margaret Dundon; Tammy Anthony
Journal:  Mil Med       Date:  2011-11       Impact factor: 1.437

2.  Beneficial effect of sulphate-bicarbonate-calcium water on gallstone risk and weight control.

Authors:  Stefano Ginanni Corradini; Flaminia Ferri; Michela Mordenti; Luigi Iuliano; Maria Siciliano; Maria Antonella Burza; Bruno Sordi; Barbara Caciotti; Maria Pacini; Edoardo Poli; Adriano De Santis; Aldo Roda; Carolina Colliva; Patrizia Simoni; Adolfo Francesco Attili
Journal:  World J Gastroenterol       Date:  2012-03-07       Impact factor: 5.742

Review 3.  The global epidemic of obesity: are we becoming more sympathetic?

Authors:  Kevin P Davy
Journal:  Curr Hypertens Rep       Date:  2004-06       Impact factor: 5.369

4.  The effect of dehydroleucodine in adipocyte differentiation.

Authors:  Adriana Galvis; Adriana Marcano; Chad Stefancin; Nicole Villaverde; Horacio A Priestap; Carlos E Tonn; Luis A Lopez; Manuel A Barbieri
Journal:  Eur J Pharmacol       Date:  2011-09-19       Impact factor: 4.432

Review 5.  Impact of postprandial glycaemia on health and prevention of disease.

Authors:  E E Blaak; J-M Antoine; D Benton; I Björck; L Bozzetto; F Brouns; M Diamant; L Dye; T Hulshof; J J Holst; D J Lamport; M Laville; C L Lawton; A Meheust; A Nilson; S Normand; A A Rivellese; S Theis; S S Torekov; S Vinoy
Journal:  Obes Rev       Date:  2012-07-11       Impact factor: 9.213

6.  Stochastic variability in stress, sleep duration, and sleep quality across the distribution of body mass index: insights from quantile regression.

Authors:  Tse-Chuan Yang; Stephen A Matthews; Vivian Y-J Chen
Journal:  Int J Behav Med       Date:  2014-04

Review 7.  Implications of adiponectin in linking metabolism to testicular function.

Authors:  Luc J Martin
Journal:  Endocrine       Date:  2013-11-28       Impact factor: 3.633

8.  Regulatory challenges for new drugs to treat obesity and comorbid metabolic disorders.

Authors:  David J Heal; Jane Gosden; Sharon L Smith
Journal:  Br J Clin Pharmacol       Date:  2009-12       Impact factor: 4.335

9.  Obesity increases the risks of diverticulitis and diverticular bleeding.

Authors:  Lisa L Strate; Yan L Liu; Walid H Aldoori; Sapna Syngal; Edward L Giovannucci
Journal:  Gastroenterology       Date:  2008-09-25       Impact factor: 22.682

Review 10.  Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease: an epidemiological perspective.

Authors:  José Alejandro Luchsinger
Journal:  Eur J Pharmacol       Date:  2008-03-04       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.